A Cross-Sectional Study of Psychiatric Manifestations Following Oseltamivir Administration for Suspected Patients with H1N1 Swine Influenza Infection
Introduction: Oseltamivir is an antiviral drug used to treat H1N1 influenza. FDA added a warning to the label of oseltamivir drawing attention to the risk of developing neuropsychiatric adverse events. There are some case reports reported psychiatric symptoms on oseltamivir intake. However, data is...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Mashhad University of Medical Sciences
2022-03-01
|
Series: | Journal of Cardio-Thoracic Medicine |
Subjects: | |
Online Access: | https://jctm.mums.ac.ir/article_19832_57ba3d48b9f94f5c982cc3fbcb2974f2.pdf |